Vestigial Like 3 (VGLL3) (Middle Region) Peptid
VGLL3
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle VGLL3 Produkte
- VGLL3 (Vestigial Like 3 (VGLL3))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-VGLL3 antibody (Catalog #: ARP55341_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VGLL3 (Vestigial Like 3 (VGLL3))
- Hintergrund
-
VGLL3 belongs to the vestigial family. It may act as a specific coactivator for the mammalian TEFs.
Alias Symbols: DKFZp686O1845, FLJ38507, VGL-3, VGL3
Protein Size: 326 - Molekulargewicht
- 36 kDa
- Gen-ID
- 389136
- NCBI Accession
- NM_016206, NP_057290
- UniProt
- A8MV65
-
Sie sind hier:
